Cimzia

In the US, Cimzia (certolizumab systemic) is a member of the drug class TNF alfa inhibitors and is used to treat Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance and Rheumatoid Arthritis.

US matches:

• Cimzia

UK matches:

• Cimzia 200 mg solution for injection (SPC)

Ingredient matches for Cimzia

Certolizumab

Certolizumab Pegol is reported as an ingredient of Cimzia in the following countries:

• Finland


• Germany


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.